NCT00717340 2012-06-28A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast CancerAVEO Pharmaceuticals, Inc.Phase 1 Completed18 enrolled